Remove Hurdles to Cancer Care


COVID-19 has shone a spotlight on the significant barriers to affordable health care that cancer patients have long faced. While relief packages and proposals to date have worked to address affordability of COVID-specific testing and treatment, policymakers must also tackle hurdles that cancer patients face like removing the red tape of prior authorization and step therapy, reducing out-of-pocket costs, and ensuring cost-sharing assistance directly benefits patients. There has been a great deal of research and investment in effective therapies that allow people fighting cancer to survive and live longer. Cancer patients need Congress to act quickly to remove hurdles to quality care.

56% of cancer patients and survivors are worried about being able to afford their treatment

Latest Updates

December 17, 2021
New York

ACS CAN looks forward to working with the new New York City Mayor and City Council Speaker on crucial health issues.

November 18, 2021

COLUMBUS, OHIO – “Today, the Ohio House passed HB 218, which allows vague and subjective exemptions to vaccine requirements based on reasons of conscience. As an employer and advocate for cancer patients, the American Cancer Society (ACS) needs to be able to make decisions in the best interest of its

October 13, 2021

COLUMBUS, OHIO – “Today, the Ohio House paused HB 435, which allows vague and subjective exemptions to vaccine mandates based on reasons of conscience. The American Cancer Society’s (ACS) right to make decisions in the best interest of their employees, the cancer patients they serve and the right of cancer

September 2, 2021

This year roughly 10,240 Idahoans will be diagnosed with cancer. Thanks in part to advances in cancer research and treatment, we are saving more lives than ever. But cancer remains a critical public health problem and getting new and affordable therapies from the research lab to the patient will require

Remove Hurdles to Cancer Care Resources

In these comments, ACS CAN strongly supports Congress’ and the Administration’s efforts to protect patients from surprise medical bills and we are encouraged by the important steps this interim final rule takes. Specifically, we applaud the Departments’ proposed policies related to:

Where healthcare dollars are spent compared with dollars on cancer care, 2018.

Cancer patients are particularly vulnerable to spikes in their health care costs because many expensive diagnostic tests and treatments are scheduled within a short period of time, so cancer patients spend their deductible and out-of-pocket maximum quickly. These costs can be difficult to manage over the course of a year, and most monthly budgets simply can’t afford these large bills.